Bilaketaren emaitzak - Sadayoshi Ito

Findu emaitzak
  1. 1
    Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics.

    Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. nork Sadayoshi Ito, Yufeng Ren

    Argitaratua 1993
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Pulse Pressure Amplification, Arterial Stiffness, and Peripheral Wave Reflection Determine Pulsatile Flow Waveform of the Femoral Artery

    Pulse Pressure Amplification, Arterial Stiffness, and Peripheral Wave Reflection Determine Pulsatile Flow Waveform of the Femoral Artery nork Junichiro Hashimoto, Sadayoshi Ito

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Aortic Stiffness Determines Diastolic Blood Flow Reversal in the Descending Thoracic Aorta

    Aortic Stiffness Determines Diastolic Blood Flow Reversal in the Descending Thoracic Aorta nork Junichiro Hashimoto, Sadayoshi Ito

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Central Pulse Pressure and Aortic Stiffness Determine Renal Hemodynamics

    Central Pulse Pressure and Aortic Stiffness Determine Renal Hemodynamics nork Junichiro Hashimoto, Sadayoshi Ito

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  5. 5
    An in vitro approach to the study of macula densa-mediated glomerular hemodynamics

    An in vitro approach to the study of macula densa-mediated glomerular hemodynamics nork Sadayoshi Ito, Oscar A. Carretero

    Argitaratua 1990
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Role of the macula densa in renin release.

    Role of the macula densa in renin release. nork Sadayoshi Ito, Oscar A. Carretero

    Argitaratua 1985
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.

    Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. nork Naoshi Ueda, K Kuno, Sadayoshi Ito

    Argitaratua 1990
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    Possible role of adenosine in the macula densa mechanism of renin release in rabbits.

    Possible role of adenosine in the macula densa mechanism of renin release in rabbits. nork Sadayoshi Ito, Oscar A. Carretero, Robert Murray

    Argitaratua 1985
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole.

    Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. nork Sadayoshi Ito, Cynthia S. Johnson, Oscar A. Carretero

    Argitaratua 1991
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk

    Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk nork Sadayoshi Ito, Tasuku Nagasawa, Michiaki Abe, Takefumi Mori

    Argitaratua 2009
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study

    Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study nork Sadayoshi Ito, Hiroshi Itoh, Hiromi Rakugi, Yasuyuki Okuda, Satoru Yamakawa

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria

    Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria nork Sadayoshi Ito, Kenichi Shikata, Masaomi Nangaku, Yasuyuki Okuda, Tomoko Sawanobori

    Argitaratua 2019
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study

    Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label... nork Hiroshi Itoh, Sadayoshi Ito, Hiromi Rakugi, Yasuyuki Okuda, Satoshi Nishioka

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension

    Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension nork Hiromi Rakugi, Sadayoshi Ito, Hiroshi Itoh, Yasuyuki Okuda, Satoru Yamakawa

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction

    Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction nork Sadayoshi Ito, Hiroshi Itoh, Hiromi Rakugi, Yasuyuki Okuda, Setsuko Iijima

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Flow modulates myogenic responses in isolated microperfused rabbit afferent arterioles via endothelium-derived nitric oxide.

    Flow modulates myogenic responses in isolated microperfused rabbit afferent arterioles via endothelium-derived nitric oxide. nork Luis A. Juncos, James H. Garvin, Oscar A. Carretero, Sadayoshi Ito

    Argitaratua 1995
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    Angiotensin II Type 1 Receptor Blockers Reduce Urinary Oxidative Stress Markers in Hypertensive Diabetic Nephropathy

    Angiotensin II Type 1 Receptor Blockers Reduce Urinary Oxidative Stress Markers in Hypertensive Diabetic Nephropathy nork Susumu Ogawa, Takefumi Mori, Kazuhiro Nako, T. KATO, Kazuhisa Takeuchi, Sadayoshi Ito

    Argitaratua 2006
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome

    The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome nork Miho Senda, Susumu Ogawa, Kazuhiro Nako, Masashi Okamura, Takuya Sakamoto, Sadayoshi Ito

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial

    A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial nork Masaaki Nakayama, Hideki Nakano, Hiromi Hamada, Noritomo Itami, Ryoichi Nakazawa, Sadayoshi Ito

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)

    Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study) nork Sadayoshi Ito, Hiroshi Itoh, Hiromi Rakugi, Yasuyuki Okuda, M. Yoshimura, Satoru Yamakawa

    Argitaratua 2019
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: